Email: info@ivascular.global | Tel: +34 936 724 711
EN
Site logo
Sticky header logo
  • About us
    • Company
    • Philosophy
    • Vertical integration
    • Group
    • iVascular worldwide
  • Therapeutic areas
    • Coronary
      • angiolite
      • essential pro
      • essential
      • navitian
      • architect
      • capturer
      • xperience
      • NC xperience
      • xperience pro
    • Peripheral
      • luminor
      • iVolution
      • restorer
      • sergeant NEW
      • angiolite BTK
      • oceanus
      • nautilus
  • Clinical Trials
    • EFFPAC Trial
    • ANGIOLITE Trial
    • ANCHOR Trial
    • EVOLUTION Trial
    • LUMINOR Registry
    • TINTIN Trial
    • ANGIOLITE BTK Trial
    • MERLION Trial
    • BIBLIOS Trial
    • ESSENTIAL in Small Vessels Registry
    • RANGO Registry
    • ESSENTIAL ISR Trial
  • Healthcare Professionals
    • PMS
      • luminor DCB
      • angiolite DES
      • Peripheral stents
      • essential – essential pro
    • iVascular Grant
  • Careers
    • Work with us
    • Jobs board
  • News
  • Contact
Site logo
Sticky header logo
Site logo
Sticky header logo
EN

Blog categories

  • All (21)
  • Clinical Trials (24)
  • Congresses (17)
  • Coronary (11)
  • Coronary and peripheral news (11)
  • Partnership (3)
  • Peripheral (24)

Comments

    All iVascular launches LUMIFOLLOW trial in Europe for the treatment of femoropopliteal lesions with Luminor DCB
    February 11, 2021

    iVascular launches LUMIFOLLOW trial in Europe for the treatment of femoropopliteal lesions with Luminor DCB

    Read more
    Coronary iVascular, Angiolite DES offers new long lengths of 44 and 49mm.
    February 9, 2021

    iVascular, Angiolite DES offers new long lengths of 44 and 49mm.

    Read more
    All iVascular – New BTK evidence with Luminor DCB: MERLION Trial 1 year follow-up
    February 4, 2021

    iVascular – New BTK evidence with Luminor DCB: MERLION Trial 1 year follow-up

    Read more
    All New outcomes confirm Luminor DCB outstanding performance in femoropopliteal complex lesions and in long-term follow-up
    February 4, 2021

    New outcomes confirm Luminor DCB outstanding performance in femoropopliteal complex lesions and in long-term follow-up

    Read more
    All iVascular, Angiolite 6.00mm maximum overexpansion capacity.
    January 13, 2021

    iVascular, Angiolite 6.00mm maximum overexpansion capacity.

    Read more
    Clinical Trials Angiolite is now reimbursed in Belgium.
    September 3, 2020

    Angiolite is now reimbursed in Belgium.

    Read more
    Clinical Trials EffPac trial 2-year review on mortality confirms the safety of Luminor DCB
    September 3, 2020

    EffPac trial 2-year review on mortality confirms the safety of Luminor DCB

    Read more
    All iVascular is pleased to announce the launch of sergeant, a new peripheral support catheter
    July 10, 2020

    iVascular is pleased to announce the launch of sergeant, a new peripheral support catheter

    Read more
    All iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.
    June 26, 2020

    iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.

    Read more
    All iVascular COVID 19 letter
    June 15, 2020

    iVascular COVID 19 letter

    Read more
    All iVascular – essential pro, new coronary drug coated balloon
    June 15, 2020

    iVascular – essential pro, new coronary drug coated balloon

    Read more
    Congresses iVascular, innovation and passion at the interactive Vascular Summit 2020.
    March 2, 2020

    iVascular, innovation and passion at the interactive Vascular Summit 2020.

    Read more
    Prev

    Posts navigation

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    Next

    Search

    Recent Posts

    • iVascular launches LUMIFOLLOW trial in Europe for the treatment of femoropopliteal lesions with Luminor DCB February 11, 2021
    • iVascular, Angiolite DES offers new long lengths of 44 and 49mm. February 9, 2021
    • iVascular – New BTK evidence with Luminor DCB: MERLION Trial 1 year follow-up February 4, 2021
    • New outcomes confirm Luminor DCB outstanding performance in femoropopliteal complex lesions and in long-term follow-up February 4, 2021
    • iVascular, Angiolite 6.00mm maximum overexpansion capacity. January 13, 2021

    Categories

    • All
    • Clinical Trials
    • Congresses
    • Coronary
    • Coronary and peripheral news
    • Partnership
    • Peripheral
    iVascular Advanced Medical Devices and Therapies
    iVascular S.L.U. | Camí de Can Ubach, 11 (Pol. Ind. Les Fallulles)
    08620 Sant Vicenç dels Horts | Barcelona
    Tel.: +34 936 724 711 | Fax: +34 936 724 657
    Email: info@ivascular.global

    Privacy Policy | Cookie Policy | Legal Disclaimer

     #main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}

    Utilizamos cookies para garantizar la mejor experiencia en su navegación. Si continúa navegando considere aceptar el uso de cookies. Más información

    Privacy Preference Center

    • Política de Privacidad
    • Cookie Privacy

    Consent Management

    Política de Privacidad

    Required
    Introducción La presente Política de Privacidad ha sido desarrollada teniendo en cuenta lo dispuesto por la Ley Orgánica de Protección de Datos de carácter personal en vigor, así como por el Reglamento 2016/679 del Parlamento Europeo y del consejo del 27 de abril de 2016 relativo a la protección de las personas físicas en lo que respecta al tratamiento de datos personales y a la circulación de estos datos, en adelante el RGPD. Esta Política de Privacidad tiene por objeto poner en conocimiento de los titulares de los datos personales, respecto de los cuales se está recabando información, los aspectos específicos relativos al tratamiento sus datos, entre otras cosas, las finalidades de los tratamientos, los datos de contacto para ejercer los derechos que le asisten, los plazos de conservación de la información y las medidas de seguridad entre otras cosas.

    Cookie Privacy

    Required
    Sus principales funciones son: Llevar el control de usuarios: cuando un usuario introduce su nombre de usuario y contraseña, se almacena una cookie para que no tenga que estar introduciéndolas para cada página del servidor. Sin embargo, una cookie no identifica solo a una persona, sino a una combinación de computador-navegador-usuario. Conseguir información sobre los hábitos de navegación del usuario, e intentos de spyware (programas espía), por parte de agencias de publicidad y otros. Esto puede causar problemas de privacidad y es una de las razones por la que las cookies tienen sus detractores.

    Necessary

    Analytics

    Session-only

    Cookies Used

    Google Analytics

    Other